Xinyong Liu
- Biomaterials top 10%
- Virology top 10%
- Organic Chemistry top 10%
- Synthesis and Biological Evaluation 3
-
- HIV/AIDS drug development and treatment 4
- SARS-CoV-2 and COVID-19 Research 3
- Pharmaceutical Science top 10%
-
- Influenza Virus Research Studies 7
-
- Computational Drug Discovery Methods 4
-
- interferon and immune responses 3
-
- Peptidase Inhibition and Analysis 3
-
- Receptor Mechanisms and Signaling 3
Xinyong Liu
30 papers receiving 774 citations
Peers
Comparison fields: 5 of 98
- Biomaterials 114
- Virology 36
- Organic Chemistry 210
- Infectious Diseases 101
- Pharmaceutical Science 28
Countries citing papers authored by Xinyong Liu
This map shows the geographic impact of Xinyong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyong Liu more than expected).
Fields of papers citing papers by Xinyong Liu
This network shows the impact of papers produced by Xinyong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyong Liu. The network helps show where Xinyong Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xinyong Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 9 | |
| 5 | 2023 | 10 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 27 | |
| 8 | 2023 | 10 | |
| 9 | 2022 | 3 | |
| 10 | 2021 | 21 | |
| 11 | 2020 | 23 | |
| 12 | 2019 | 36 | |
| 13 | 2019 | 3 | |
| 14 | 2018 | 45 | |
| 15 | 2014 | 32 | |
| 16 | 2012 | 17 | |
| 17 | 2011 | 17 | |
| 18 | 2008 | 6 | |
| 19 | Synthesis of Clinofibrate | 2007 | 0 |
| 20 | 2005 | 58 |
About Xinyong Liu
Xinyong Liu is a scholar working on Infectious Diseases, Pollution and Epidemiology, having authored 33 papers that have together received 784 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (7 papers), HIV/AIDS drug development and treatment (4 papers), Computational Drug Discovery Methods (4 papers), interferon and immune responses (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Peptidase Inhibition and Analysis (3 papers), Synthesis and Biological Evaluation (3 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Biomaterials (114 citations), Virology (36 citations) and Organic Chemistry (210 citations). Xinyong Liu has collaborated with scholars based in China, Belgium and Spain. Frequent co-authors include Erik De Clercq, Peng Zhan, Peng Zhan, Wenjun Li, Hong‐Xiang Lou, Dongwei Kang, Fei Yang, Zhijie Yang, Lin Sun and Jian Zhang. Their work appears in journals such as Acta Pharmaceutica Sinica B, Antiviral Research, European Journal of Medicinal Chemistry, Mini-Reviews in Medicinal Chemistry and Environmental Monitoring and Assessment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.